Vancomycin

Kathryn Dzintars, Pharm.D., BCPS
Pediatric Dosing Author: Alice Jenh Hsu, PharmD, BCPS, AQ-ID

INDICATIONS

FDA

  • Treatment of serious or severe infections caused by susceptible strains of MRSA
  • Initial therapy when MRSA is suspected
  • Oral vancomycin: antibiotic-associated pseudomembranous colitis caused by C. difficile and enterocolitis caused by S. aureus (including MRSA)

NON-FDA APPROVED USES

There's more to see -- the rest of this topic is available only to subscribers.

Last updated: August 9, 2019